Background: We summarized the protocol-specified corticosteroid tapering regimens in clinical trials of moderate-severe ulcerative colitis (UC) and Crohn’s disease (CD) and calculated differences in rates of clinical remission vs corticosteroid-free clinical remission (CSF-CR).


End Points, Maintenance Therapy, Adrenal Cortex Hormones, Crohn's Disease, Clinical Trials, Drug Therapy, Ulcerative Colitis, therapeutic use, Biological Products

Read More